McGrath, L. J., Spangler, L., Curtis, J. R., Ehrenstein, V., Sorensen, H. T., Saul, B., … Bradbury, B. D. (2019). Using Negative Control Outcomes to Assess the Comparability of Osteoporosis Treatment Groups. In Pharmacoepidemiology and Drug Safety (Vol. 28, pp. 27–28). WILEY.

McGrath, Leah J., Leslie Spangler, Jeffrey R. Curtis, Vera Ehrenstein, Henrik Toft Sorensen, Bradley Saul, Sara Levintow, M Alan Brookhart, and Brian D. Bradbury. “Using Negative Control Outcomes to Assess the Comparability of Osteoporosis Treatment Groups.” In Pharmacoepidemiology and Drug Safety, 28:27–28. WILEY, 2019.

McGrath LJ, Spangler L, Curtis JR, Ehrenstein V, Sorensen HT, Saul B, et al. Using Negative Control Outcomes to Assess the Comparability of Osteoporosis Treatment Groups. In: Pharmacoepidemiology and Drug Safety. WILEY; 2019. p. 27–8.

McGrath, Leah J., et al. “Using Negative Control Outcomes to Assess the Comparability of Osteoporosis Treatment Groups.” Pharmacoepidemiology and Drug Safety, vol. 28, WILEY, 2019, pp. 27–28.

McGrath LJ, Spangler L, Curtis JR, Ehrenstein V, Sorensen HT, Saul B, Levintow S, Brookhart MA, Bradbury BD. Using Negative Control Outcomes to Assess the Comparability of Osteoporosis Treatment Groups. Pharmacoepidemiology and Drug Safety. WILEY; 2019. p. 27–28.